Beijing Scitop Bio-tech Co

Beijing Scitop Bio-tech Co Financial Leverage

The Financial Leverage (Equity Multiplier) of Beijing Scitop Bio-tech Co (300858.SZ) as of Oct 27, 2026 is 1.10. In the previous year, Financial Leverage (Equity Multiplier) was 1.07 — a change of 2.35% (higher).

Financial Leverage

1.10

YoY

2.35%

Last updated:

Financial Leverage (Equity Multiplier) of Beijing Scitop Bio-tech Co is 2025 1.10 . Financial Leverage (Equity Multiplier) of Beijing Scitop Bio-tech Co was 2024 1.07 . It decreases by 2.35% higher compared to the previous year.

The Beijing Scitop Bio-tech Co Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
1.24 CNY
Jan 1, 2019
1.17 CNY
Jan 1, 2020
1.07 CNY
Jan 1, 2021
1.08 CNY
Jan 1, 2022
1.06 CNY
Jan 1, 2023
1.04 CNY
Jan 1, 2024
1.07 CNY
Jan 1, 2025
1.10 CNY
The Beijing Scitop Bio-tech Co Financial Leverage history
YEARFinancial LeverageYoY
1.10+2.35%
1.07+2.48%
1.04-1.03%
1.06-1.90%
1.08+0.40%
1.07-8.06%
1.17-5.88%
1.24+3.16%
1.20-12.95%
1.38-60.65%
3.50—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Beijing Scitop Bio-tech Co Stock analysis

What does Beijing Scitop Bio-tech Co do? Beijing Scitop Bio-tech Co Ltd is a company based in Beijing, China, operating within the Consumer Staples sector, specifically in the Food Products industry. The company focuses on the research and development, production, and sale of compound food additives. It has a workforce of 263 employees. Beijing Scitop Bio-tech Co Ltd completed its initial public offering (IPO) on July 27, 2020, and is listed on the Shenzhen Stock Exchange under the ticker symbol 300858.SZ. The company's website is http://www.scitop.cn/. Its primary products include compound food additives, edible probiotic products, and animal and plant microecological preparations. The firm conducts its business operations predominantly within the Chinese market. The company's headquarters are located in Beijing, and it serves as a provider of food-related products and solutions. The company's activities are centered around the development and commercialization of food additives and related products, aiming to meet the demands of the domestic food industry. As a publicly traded entity, it is subject to the regulatory requirements of the Shenzhen Stock Exchange. The company's operations are confined to the China market, with no mention of international expansion or significant overseas operations in the provided information. Beijing Scitop Bio-tech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Beijing Scitop Bio-tech Co stock

Financial Leverage (Equity Multiplier) of Beijing Scitop Bio-tech Co is 1.10 in 2025.

Financial Leverage (Equity Multiplier) of Beijing Scitop Bio-tech Co changed from 1.07 to 1.10, representing a 2.35% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Beijing Scitop Bio-tech Co since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Beijing Scitop Bio-tech Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Beijing Scitop Bio-tech Co

All Key Metrics — Beijing Scitop Bio-tech Co